Why the study?
Does cigarette smoking increase laboratory aspirin resistance in healthy males?
Does cigarette smoking increase laboratory aspirin resistance in healthy males?
Cigarette smoking does not appear to significantly affect laboratory aspirin resistance measured by platelet aggregation in healthy males.
Smoking was not associated with aspirin resistance in healthy males; leaves open effects on clinical outcomes or other populations.
Based on the Framingham study, it was revealed that cigarette smoking can cause athero- thrombotic cardiovascular disease (CVD).Aspirin is the most widely used anti platelet drug in CVD; it reduces the risk of the secondary events by about 25% in cardiovasculardisease. Lately, it was reported that 5–45% of these patients are resistant to aspirin. The researchers aimed to investigate in this study theimpact of cigarette smoking on aspirin resistance. Twenty two smokers and 18 non-smokers were enrolled in this study. The researchersrequired all of the 40 subjects to take 160 mg of aspirin after the first blood sample was taken. The first sample was taken in the morning,while the second one was obtained two (2) hours after the aspirin intake. Platelet aggregation was performed using a light transmittanceaggregometry (LTA). Aspirin resistance was found in two (2) of 22 smokers (9.09%) and two (2) of 18 non-smokers (11.11%). There wereno significant differences (p>0.05) before or after taking aspirin in either both smokers or non smokers as seen from the aggregationresults. The researchers concluded that cigarette smoking does not cause aspirin resistance at all.
No takes yet. Share an insight, caveat, or question.
Siregar et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: